Summit Therapeutics to Present at the Biotech Showcase
January 09 2018 - 7:00AM
Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug
discovery and development company advancing therapies for rare
diseases and infectious diseases, announces that it will present at
the Biotech Showcase™, taking place 8-10 January in San Francisco,
CA, US. The presentation will take place today, 9 January, at
4:00pm PST.
A live audio webcast of the presentation will be
available through the Investors section on the Company’s website,
www.summitplc.com. A replay of the webcast will be available from
the same location soon after the live presentation.
About Summit Therapeutics
Summit is a biopharmaceutical company focused on the discovery,
development and commercialisation of novel medicines for
indications for which there are no existing or only inadequate
therapies. Summit is conducting clinical programs focused on the
genetic disease, Duchenne muscular dystrophy, and the infectious
disease, Clostridium difficile infection. Further information is
available at www.summitplc.com and Summit can be followed on
Twitter (@summitplc).
For more information, please contact:
|
|
|
Summit |
|
|
Glyn Edwards
/ Richard Pye (UK office) |
Tel: |
44 (0)1235 443 951 |
Erik Ostrowski /
Michelle Avery (US office) |
|
+1 617 225 4455 |
|
|
|
Cairn Financial
Advisers LLP (Nominated Adviser) |
Tel: |
+44 (0)20 7213
0880 |
Liam Murray / Tony
Rawlinson |
|
|
|
|
|
N+1
Singer (Joint Broker) |
Tel: |
+44 (0)20 7496
3000 |
Aubrey Powell / Jen
Boorer |
|
|
|
|
|
Panmure
Gordon (Joint Broker) |
Tel: |
+44 (0)20 7886
2500 |
Freddy Crossley /
Duncan Monteith, Corporate Finance |
|
|
Tom Salvesen, Corporate
Broking |
|
|
|
|
|
MacDougall
Biomedical Communications (US) |
Tel: |
+1 781 235 3060 |
Karen Sharma |
|
ksharma@macbiocom.com |
|
|
|
Consilium
Strategic Communications (UK) |
Tel: |
+44 (0)20 3709
5700 |
Mary-Jane Elliott / Sue
Stuart / |
|
summit@consilium-comms.com |
Jessica Hodgson /
Philippa Gardner |
|
|
-END-
Summit Therapeutics (NASDAQ:SMMT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Summit Therapeutics (NASDAQ:SMMT)
Historical Stock Chart
From Apr 2023 to Apr 2024